Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GSK3A | P49840 | 4/20 | 0.53 |
| ▸ | GSK3B | P49841 | 4/20 | 0.53 |
| ▸ | MGLL | Q99685 | 3/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.53 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.53 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.53 |
| ▸ | FAAH | O00519 | 1/20 | 0.49 |
| ▸ | CDC25B | P30305 | 1/20 | 0.48 |
| ▸ | NOTUM | Q6P988 | 1/20 | 0.45 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.45 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.45 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.45 |
| ▸ | LMNA | P02545 | 1/20 | 0.45 |
| ▸ | P2RX4 | Q99571 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14397256 | 0.89 | GSK3A (0.44) | GSK3AGSK3BMGLLALDH1A1MAPK1 | |
| SCHEMBL23298275 | 0.84 | GSK3A (0.57) | GSK3AGSK3BMGLLALDH1A1MAPK1 | |
| SCHEMBL12852134 | 0.82 | GSK3A (0.38) | GSK3AGSK3BMGLLALDH1A1MAPK1 | |
| SCHEMBL1177836 | 0.79 | ALDH1A1 (0.73) | ALDH1A1MAPK1L3MBTL1CDC25BNOTUM | |
| SCHEMBL3874763 | 0.78 | ALDH1A1 (0.63) | GSK3AGSK3BMGLLALDH1A1MAPK1 | |
| SCHEMBL7098396 | 0.78 | MGLL (0.50) | GSK3AGSK3BMGLLALDH1A1MAPK1 | |
| SCHEMBL11057704 | 0.76 | TDP1 (0.64) | GSK3AGSK3BMGLLALDH1A1FAAH | |
| SCHEMBL18673 | 0.76 | ALDH1A1 (0.68) | ALDH1A1MAPK1L3MBTL1CDC25BNOTUM | |
| SCHEMBL3963428 | 0.76 | ALDH1A1 (0.68) | ALDH1A1MAPK1L3MBTL1CDC25BNOTUM | |
| SCHEMBL21455917 | 0.76 | MGLL (0.54) | GSK3AGSK3BMGLLALDH1A1MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11795195-B2 | Antibody-drug conjugates including hemiasterlin derivative | Sumitomo Pharma Co., Ltd. (JP) | 2023-10-24 | — | — | US | disclosed |
| US-20230203474-A1 | COMPOUND, SOLID CARRIER INCLUDING THE SAME AND METHOD FOR PREPARING NUCLEIC ACID | INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) | 2023-06-29 | — | — | US | disclosed |
| US-20230203474-A1 | COMPOUND, SOLID CARRIER INCLUDING THE SAME AND METHOD FOR PREPARING NUCLEIC ACID | INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) | 2023-06-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230203474-A1 | COMPOUND, SOLID CARRIER INCLUDING THE SAME AND METHOD FOR PREPARING NUCLEIC ACID | SNRPA, NSUN2, POLRMT | GSK3A 4828/4885GSK3B 4873/4885MGLL 3810/4885 |
| US-11795195-B2 | Antibody-drug conjugates including hemiasterlin derivative | HSD3B2, HSD3B1, HSD11B2 | GSK3A 333/4885GSK3B 229/4885MGLL 4801/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.